fashion -WSS

fashion

author：fashion 2025-09-27 22:48:53 - browse：13

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： As digital health tech proliferates, a new institute aims to cut through hype

knowledge

WSS

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

IVG is promising — but it won’t replace IVF quite yet

Flu, Covid vaccination rates decline, new survey data show

CDC picks Alphabet's Verily for wasterwater surveillance contract

FDA approves RSV monoclonal antibody for infants, toddlers

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

focus

fashion

hotspot

Heart attack and stroke risk calculators need revising

Will an HIV vaccine ever be a reality?

How to save PrEP access — and even expand it

Startup Neumora takes a novel depression drug to Phase 3

At least 13 dead in Texas as scorching temps continue

Listen: Wegovy in the brain & pivotal Alzheimer's data

Heart attack and stroke risk calculators need revising

Will an HIV vaccine ever be a reality?

DIEP, the 'gold standard' of breast reconstruction, is under threat

CDC picks Alphabet's Verily for wasterwater surveillance contract

Wikipedia

6 solutions to address cancer drug shortages and others

Cosmetics set for new safety regulation. Why the industry is on board

Google and Epic fight stronger regulation of AI in health care

Biden tests positive for Covid

The Karikó problem: Lessons for funding basic research

Congress extends some pandemic preparedness programs

hotspot

knowledge

focus

Wikipedia